Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yesenia Aponte-Melendez"'
Autor:
Shashi N. Kapadia, Yesenia Aponte-Melendez, Alicia Rodriguez, Melinda Pai, Benjamin J. Eckhardt, Kristen M. Marks, Chunki Fong, Pedro Mateu-Gelabert
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-10 (2023)
Abstract Background Hepatitis C virus (HCV) treatment can effectively cure HCV among people who inject drugs (PWID). Perspectives of PWID treated in innovative models can reveal program features that address barriers to treatment, and guide implement
Externí odkaz:
https://doaj.org/article/b8a85e9c1a834d3880b26264277a9a56
Autor:
Yesenia Aponte-Melendez, Pedro Mateu-Gelabert, Chunki Fong, Benjamin Eckhardt, Shashi Kapadia, Kristen Marks
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)
Abstract Background While people who inject drugs (PWID) are vulnerable to the adverse outcomes of events like COVID-19, little is known regarding the impact of the current pandemic on PWID. We examine how COVID-19 has affected PWID in New York City
Externí odkaz:
https://doaj.org/article/1b27c61f460e485f8e7a14ae6193bc7f
Autor:
Shashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, Chunki Fong, Pedro Mateu-Gelabert, Kristen M Marks, Yesenia Aponte-Melendez, Bruce R Schackman
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 5, Iss , Pp 100109- (2022)
Background: Co-located hepatitis C treatment at syringe service programs (SSP) is an emerging model of care for people who inject drugs (PWID). Implementation of these models can be informed by understanding the program costs. Methods: We conducted a
Externí odkaz:
https://doaj.org/article/93f8b234f5194f9caf495ba509c92064
Autor:
Claire So Jeong Lee, Pedro Mateu-Gelabert, Yesenia Aponte Melendez, Chunki Fong, Shashi N Kapadia, Melinda Smith, Kristen M Marks, Benjamin Eckhardt
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0308102 (2024)
BackgroundThe main mode of transmission of Hepatitis C in North America is through injection drug use. Availability of accessible care for people who inject drugs is crucial for achieving hepatitis C elimination.ObjectiveThe objective of this analysi
Externí odkaz:
https://doaj.org/article/249c91711ee94ff0af9802042df9a079
Publikováno v:
Clin Liver Dis (Hoboken)
Autor:
Benjamin Eckhardt, Pedro Mateu-Gelabert, Yesenia Aponte-Melendez, Chunki Fong, Shashi Kapadia, Melinda Smith, Brian R. Edlin, Kristen M. Marks
Publikováno v:
JAMA Intern Med
IMPORTANCE: To achieve hepatitis C elimination, treatment programs need to engage, treat, and cure people who inject drugs. OBJECTIVE: To compare a low-threshold, nonstigmatizing hepatitis C treatment program that was colocated at a syringe service p
Autor:
Benjamin Eckhardt, Shashi N Kapadia, Pedro Mateu-Gelabert, Melinda Pai, Chunki Fong, Yesenia Aponte-Melendez, Kristen M Marks
Publikováno v:
Open forum infectious diseases. 9(7)
Background Young people who inject drugs (PWID) have high hepatitis C virus (HCV) incidence and low treatment initiation rates. Novel, simplified care models need to be developed to engage, treat, and cure hard-to-reach patient populations, such as y
Autor:
Chunki Fong, Kristen M. Marks, Yesenia Aponte-Melendez, Shashi N Kapadia, Benjamin Eckhardt, Pedro Mateu-Gelabert
Publikováno v:
Harm Reduction Journal
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)
Background While people who inject drugs (PWID) are vulnerable to the adverse outcomes of events like COVID-19, little is known regarding the impact of the current pandemic on PWID. We examine how COVID-19 has affected PWID in New York City across fo
Autor:
Benjamin Eckhardt, Shashi Kapadia, Melinda Smith, Yesenia Aponte-Melendez, Chunki Fong, La Davis, Pedro Mateu-Gelabert, Kristen Marks
Publikováno v:
Open Forum Infectious Diseases
Background Young people who inject drugs (PWID) have higher HCV incidence and lower treatment initiation rates compared to their older peers. Novel, simplified care models need to be developed to engage, treat and cure hard to reach patient populatio
Autor:
Benjamin Eckhardt, Yesenia Aponte-Melendez, Chunki Fong, Shashi Kapadia, La Davis, Melinda Smith, Pedro Mateu-Gelabert, Kristen Marks
Publikováno v:
Open Forum Infectious Diseases
Background To achieve hepatitis C virus (HCV) elimination, treatment programs need to be developed to engage, treat, and cure people who inject drugs (PWID). Methods We present final data from the Accessible Care Trial for curing HCV in PWID. The ran